CDTX
Cidara Therapeutics
CDTX
CDTX
Delisted
CDTX was delisted on the 6th of January, 2026.
251 hedge funds and large institutions have $7.36B invested in Cidara Therapeutics in 2025 Q4 according to their latest regulatory filings, with 135 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
45% more funds holding
Funds holding: 173 → 251 (+78)
37% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 46
22.2% less ownership
Funds ownership: 128.16% → 105.96% (-22%)
Holders
251
Holding in Top 10
29
Calls
$496M
Puts
$305M
Top Buyers
| 1 | +$204M | |
| 2 | +$203M | |
| 3 | +$126M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$105M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$97.2M |
Top Sellers
| 1 | -$289M | |
| 2 | -$215M | |
| 3 | -$135M | |
| 4 |
VA
VR Adviser
New York
|
-$90.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$80.9M |
